Salience Network Informed rTMS for PTSD
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- San Diego, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 84 people, planned
- Starts
- 1 Jul 2027
- Expected to end
- 31 Mar 2031
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Active MRI-Guided intermittent theta burst stimulation (iTBS)
- Sham MRI-Guided intermittent theta burst stimulation (iTBS)
- Record updated
- 16 November 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Veteran status
- Current diagnosis of posttraumatic stress disorder (PTSD), as determined by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
- Able to provide informed consent
- Able to speak, read, and write English
- Willing and able to complete 20 intermittent theta burst stimulation (iTBS) treatment sessions, scheduled 5 days per week for 4 weeks, with completion permitted within up to 6 weeks when needed
- Willing and able to complete magnetic resonance imaging (MRI) assessments before and after the iTBS treatment course
Who cannot take part
- Contraindication to magnetic resonance imaging (MRI) or transcranial magnetic stimulation (TMS), including MRI/TMS-incompatible implanted metallic or electronic devices, retained metallic foreign bodies, or other implants determined to be unsafe following MRI/TMS safety review
- Initiation of a new psychiatric medication within 4 weeks before enrollment or anticipated inability to maintain a stable medication regimen during study participation
- History of a neurological disorder associated with cognitive dysfunction, such as dementia or mild cognitive impairment
- History of traumatic brain injury associated with an estimated loss of consciousness greater than 30 minutes
- Current acute suicidal ideation or recent psychiatric hospitalization when, in the judgment of the study clinician or treating psychiatrist, the condition would interfere with safe study participation
- Current psychotic disorder or bipolar disorder/mania
- Current severe alcohol or substance use disorder; Mild or moderate alcohol or substance use disorder is not exclusionary
- History of neurosurgery when incompatible with safe MRI or TMS participation
- Vision impairment that cannot be adequately corrected for completion of study procedures
- Pregnancy; less than 3 months postpartum; or less than 3 months since cessation of breastfeeding
- Claustrophobia that would prevent completion of MRI
- Inability to lie still in the MRI scanner for approximately 60 minutes
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where in United States
- VA San Diego Healthcare System, San Diego, CASan Diego, United StatesContact: Erin T NataleNot yet recruiting
About the trial
What the trial wants to find out
The proposed study will test whether magnetic resonance imaging (MRI)-guided transcranial magnetic stimulation (TMS) can reduce posttraumatic stress disorder (PTSD) symptoms in Veterans. TMS is a noninvasive treatment that uses magnetic pulses to change activity in specific areas of the brain. In this study, MRI will be used to personalize the location of TMS based on brain networks involved in detecting and responding to important or threatening information. Veterans with PTSD will be randomly assigned to receive either active or non-active control TMS over 20 sessions. The study will examine whether active TMS improves PTSD symptoms and changes the brain circuits targeted by treatment. If effective, this approach may help improve and personalize TMS treatment for Veterans with PTSD. This project supports the Department of Veterans Affairs mission of developing more effective, biologically informed treatments for Veterans with PTSD.
The 2 groups in the trial
- Active MRI-Guided intermittent theta burst stimulation (iTBS)Treatment being tested
Participants randomized to this arm will receive 20 sessions of active intermittent theta burst stimulation (iTBS), scheduled 5 days per week for 4 weeks. When needed because of scheduling interruptions, the 20 sessions may be completed within up to 6 weeks. Treatment will be delivered to an individualized right dorsolateral prefrontal cortex target identified using MRI/fMRI-based functional connectivity.
- Sham MRI-Guided intermittent theta burst stimulation (iTBS)Sham treatment, for comparison
Participants randomized to this arm will receive 20 sessions of sham intermittent theta burst stimulation (iTBS), scheduled 5 days per week for 4 weeks. When needed because of scheduling interruptions, the 20 sessions may be completed within up to 6 weeks. The same individualized MRI/fMRI-guided treatment location and treatment schedule will be used as in the active arm.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Salience Network-guided rTMS for Veterans With PTSD
- Criteria questions
- Built from NCT07886840, who can take part
- Record updated
- 16 November 2026